Sun Pharma beats street estimates in Q3 with net profit up 16%
Sun Pharma beat Q3 estimates with a consolidated net profit of ₹3,369 crore, driven by steady domestic growth and innovative drug sales offsetting the decline in generic sales in the US.
Sun Pharma beat Q3 estimates with a consolidated net profit of ₹3,369 crore, driven by steady domestic growth and innovative drug sales offsetting the decline in generic sales in the US.
What's Your Reaction?
Economist Admin
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
